In response to Trump’s inaction, the House Energy and Commerce Committee passed a bill on Tuesday that would ban flavored tobacco products, raise the minimum age of purchase to 21, and restrict online sales of tobacco products. According to recent reporting, Trump has delayed a flavor ban. President Trump proposed two routes to tackle vaping: a ban on flavored e-cigarettes, and raising the minimum age of purchase on e-cigarettes from 18 to 21. With the number of youth e-cigarette users increasing in the last decade and roughly doubling since 2017, there may be a need for new policies that could standardize an approach to combating teenage vaping and help curb the impact on students. Administrators are struggling to combat vaping with both punitive and restorative disciplinary measures, and students continue to vape even when facing penalties as serious as suspension. Teachers and school administrators are trying, yet failing, to prevent students from vaping in classrooms and on school campuses. Teenagers are being hospitalized for vaping-related diseases, with at least one confirmed death. Third, e-cigarettes expose youth users to harmful substances, like heavy metals, and are a gateway to smoking cigarettes.Į-cigarettes are causing public health and disciplinary concerns in schools nationwide.
Second, e-cigarettes with high levels of nicotine can put youth at risk for developing a nicotine addiction which subsequently hinders brain development. First, e-cigarettes have been linked to severe lung and heart diseases. These numbers are alarming because vaping has various types of negative impacts on health. Of the youth population, 27.5% regularly use e-cigarettes, approximately 22 percentage points higher than high schoolers who smoke normal cigarettes. While Trump had suggested a ban on flavored e-cigarettes, it seems that he has backed away from that idea due to political fallout among voters.
Teen vaping has gained a significant amount of media attention since President Trump expressed concern about vaping’s public health effects in a September meeting with the FDA.
0 kommentar(er)
